New drug duo aims to tame Tough-to-Treat lymphomas
Disease control
Recruiting now
This study is testing whether combining two existing drugs—pembrolizumab and ATRA—can help control Hodgkin lymphoma or B-cell non-Hodgkin lymphoma that has returned or stopped responding to other treatments. It will enroll about 24 adults to see if the combination is safe and can…
Phase: PHASE2 • Sponsor: Rita Assi • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC